CN109010520A - A kind of ointment and preparation method thereof for treating dark sore - Google Patents
A kind of ointment and preparation method thereof for treating dark sore Download PDFInfo
- Publication number
- CN109010520A CN109010520A CN201810911680.0A CN201810911680A CN109010520A CN 109010520 A CN109010520 A CN 109010520A CN 201810911680 A CN201810911680 A CN 201810911680A CN 109010520 A CN109010520 A CN 109010520A
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- oil
- essential oil
- leaf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002674 ointment Substances 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims description 10
- 239000000341 volatile oil Substances 0.000 claims abstract description 45
- 239000003921 oil Substances 0.000 claims abstract description 25
- 241001407408 Berberis fortunei Species 0.000 claims abstract description 21
- 235000002991 Coptis groenlandica Nutrition 0.000 claims abstract description 21
- 244000247747 Coptis groenlandica Species 0.000 claims abstract description 21
- 244000086363 Pterocarpus indicus Species 0.000 claims abstract description 21
- 235000009984 Pterocarpus indicus Nutrition 0.000 claims abstract description 21
- 241001295692 Pyracantha fortuneana Species 0.000 claims abstract description 20
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims abstract description 19
- 244000192528 Chrysanthemum parthenium Species 0.000 claims abstract description 19
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 19
- 235000008384 feverfew Nutrition 0.000 claims abstract description 19
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 18
- 235000016140 Artemisia frigida Nutrition 0.000 claims abstract description 18
- 240000004573 Artemisia frigida Species 0.000 claims abstract description 18
- 235000013717 Houttuynia Nutrition 0.000 claims abstract description 18
- 244000178870 Lavandula angustifolia Species 0.000 claims abstract description 18
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims abstract description 18
- 239000001913 cellulose Substances 0.000 claims abstract description 18
- 235000010980 cellulose Nutrition 0.000 claims abstract description 18
- 229920002678 cellulose Polymers 0.000 claims abstract description 18
- 210000001652 frontal lobe Anatomy 0.000 claims abstract description 18
- 239000001102 lavandula vera Substances 0.000 claims abstract description 18
- 235000018219 lavender Nutrition 0.000 claims abstract description 18
- 229940105902 mint extract Drugs 0.000 claims abstract description 18
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 18
- 239000000661 sodium alginate Substances 0.000 claims abstract description 18
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 18
- 240000000691 Houttuynia cordata Species 0.000 claims abstract description 17
- 235000002594 Solanum nigrum Nutrition 0.000 claims abstract description 17
- 235000013832 Valeriana officinalis Nutrition 0.000 claims abstract description 17
- 244000126014 Valeriana officinalis Species 0.000 claims abstract description 17
- 235000010489 acacia gum Nutrition 0.000 claims abstract description 17
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims abstract description 17
- 235000016788 valerian Nutrition 0.000 claims abstract description 17
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims abstract description 16
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims abstract description 16
- 239000010667 rosehip oil Substances 0.000 claims abstract description 15
- 244000061457 Solanum nigrum Species 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 238000004945 emulsification Methods 0.000 claims description 19
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 15
- 238000012545 processing Methods 0.000 claims description 15
- 239000000839 emulsion Substances 0.000 claims description 11
- 238000001914 filtration Methods 0.000 claims description 10
- 239000012530 fluid Substances 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 10
- 239000002893 slag Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 9
- 235000013399 edible fruits Nutrition 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 239000006071 cream Substances 0.000 claims description 4
- 240000002307 Solanum ptychanthum Species 0.000 claims 3
- 239000004744 fabric Substances 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 30
- 208000002874 Acne Vulgaris Diseases 0.000 description 11
- 206010000496 acne Diseases 0.000 description 11
- 230000000694 effects Effects 0.000 description 9
- 206010061218 Inflammation Diseases 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 6
- 230000001804 emulsifying effect Effects 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- 239000002562 thickening agent Substances 0.000 description 5
- 206010017553 Furuncle Diseases 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 210000003780 hair follicle Anatomy 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 210000002808 connective tissue Anatomy 0.000 description 3
- 230000000249 desinfective effect Effects 0.000 description 3
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 3
- 239000001685 glycyrrhizic acid Substances 0.000 description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 3
- 235000019410 glycyrrhizin Nutrition 0.000 description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 230000037307 sensitive skin Effects 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 239000002344 surface layer Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000186427 Cutibacterium acnes Species 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 244000170916 Paeonia officinalis Species 0.000 description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 241000220317 Rosa Species 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 206010048038 Wound infection Diseases 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 208000003512 furunculosis Diseases 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 229940055019 propionibacterium acne Drugs 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- NEPMMBQHELYZIW-YMTXFHFDSA-N sakuranin Chemical compound O([C@@H](CC(=O)C1=2)C=3C=CC(O)=CC=3)C1=CC(OC)=CC=2O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NEPMMBQHELYZIW-YMTXFHFDSA-N 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 229940096998 ursolic acid Drugs 0.000 description 2
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 2
- RSWGJHLUYNHPMX-UHFFFAOYSA-N 1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylic acid Chemical compound C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 208000036828 Device occlusion Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 241000758769 Houttuynia Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241001163113 Photinia glabra Species 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 208000002029 allergic contact dermatitis Diseases 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000003399 chemotactic effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 210000000613 ear canal Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/33—Cactaceae (Cactus family), e.g. pricklypear or Cereus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/84—Valerianaceae (Valerian family), e.g. valerian
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/31—Extraction of the material involving untreated material, e.g. fruit juice or sap obtained from fresh plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
The present invention discloses a kind of ointment for treating dark sore, raw material including following parts by weight proportion: 28-33 parts of Chinese mahonia leaf, 32-35 parts of pyracantha fortuneana leaf, 12-25 parts of folium photiniae, 8-16 parts of flatcar frontal lobe, 7-9 parts of prairie sagewort, 11-15 parts of herba lysimachiae, 24-26 parts of Solanum nigrum, 15-20 parts of the coptis, 2-4 parts of Huai Goat, 1-3 parts of houttuynia extract, 5-7 parts of Feverfew P.E, 1-3 parts of Valerian root P.E, 8-14 parts of Radix et Caulis Opuntiae Dillenii extract, 3-5 parts of mint extract, 2-7 parts of dipotassium glycyrrhizinate, 9-11 parts of sodium alginate, permanent 5-7 parts of flower essential oil, 2-4 parts of Lavender, 5-6 parts of rosewood essential oil, 86-90 parts of house oil, 10-13 parts of rose hip oil, 5-8 parts of Arabic gum and pico- crystalline cellulose 8-14 parts, the ointment of the treatment dark sore can effectively treat dark sore.
Description
Technical field
The present invention relates to a kind of ointment and preparation method thereof for treating dark sore.
Background technique
Dark sore refers generally to acne, and acne is a kind of chronic inflammatory skin of pilosebaceous unit, is mainly apt to occur in
Teenager, it is very big to teen-age psychology and social influence, but tend to nature after puberty and mitigate or fully recover.Clinical manifestation with
It is apt to occur in the characteristics of the pleomorphism skin lesions such as acne, papule, warts, the tubercle of face.
The generation of acne mainly with hypersteatosis, pilosebaceous duct blocking, bacterium infection and inflammatory reaction etc.
Factor is closely related.The level of androgen especially testosterone in descendant's body that adolesces increases rapidly, promotes sebaceous glands development
And generate a large amount of sebums.The dyskeratosis of pilosebaceous duct causes catheter blockage simultaneously, and dyssebacia forms cutin
Bolt, that is, micro mist thorn.Multiple-microorganism especially propionibacterium acnes mass propagation in hair follicle, the lipase that propionibacterium acnes generate
It decomposes sebum and generates free fatty acid, while chemotactic inflammatory cell and medium, finally induce and aggravate inflammatory reaction.Acne cream is
A kind of ointment, for treating dark sore, current acne cream using effect is not satisfactory.
Summary of the invention
The technical problem to be solved in the present invention is to provide one kind can effectively treat dark sore treatment dark sore ointment and
Preparation method.
To solve the above problems, the present invention adopts the following technical scheme:
A kind of ointment and preparation method thereof for treating dark sore, the raw material including following parts by weight proportion: Chinese mahonia leaf
28-33 parts, 32-35 parts of pyracantha fortuneana leaf, 12-25 parts of folium photiniae, 8-16 parts of flatcar frontal lobe, 7-9 parts of prairie sagewort, 11-15 parts of herba lysimachiae, dragon
24-26 parts of certain herbaceous plants with big flowers fruit, 15-20 parts of the coptis, 2-4 parts of Huai Goat, 1-3 parts of houttuynia extract, 5-7 parts of Feverfew P.E,
1-3 parts of Valerian root P.E, 8-14 parts of Radix et Caulis Opuntiae Dillenii extract, 3-5 parts of mint extract, 2-7 parts of dipotassium glycyrrhizinate, sodium alginate 9-
11 parts, flower essential oil 5-7 parts permanent, 2-4 parts of Lavender, 5-6 parts of rosewood essential oil, 86-90 parts of house oil, rose hip oil 10-
13 parts, 5-8 parts of Arabic gum and pico- 8-14 parts of crystalline cellulose.
Further, the raw material including following parts by weight proportion: 28 parts of Chinese mahonia leaf, 32 parts of pyracantha fortuneana leaf, folium photiniae
12 parts, 8 parts of flatcar frontal lobe, 7 parts of prairie sagewort, 11 parts of herba lysimachiae, 24 parts of Solanum nigrum, 15 parts of the coptis, 2 parts of Huai Goat, cordate houttuynia
1 part of extract, 5 parts of Feverfew P.E, 1 part of Valerian root P.E, 8 parts of Radix et Caulis Opuntiae Dillenii extract, 3 parts of mint extract, glycyrrhizic acid
2 parts of dipotassium, 9 parts of sodium alginate, 5 parts of permanent flower essential oil, 2 parts of Lavender, 5 parts of rosewood essential oil, 86 parts of house oil, fructus rosae
10 parts of oil, 5 parts of Arabic gum and pico- 8 parts of crystalline cellulose.
Further, the raw material including following parts by weight proportion: 33 parts of Chinese mahonia leaf, 35 parts of pyracantha fortuneana leaf, folium photiniae
25 parts, 16 parts of flatcar frontal lobe, 9 parts of prairie sagewort, 15 parts of herba lysimachiae, 26 parts of Solanum nigrum, 20 parts of the coptis, 4 parts of Huai Goat, cordate houttuynia
3 parts of extract, 7 parts of Feverfew P.E, 3 parts of Valerian root P.E, 14 parts of Radix et Caulis Opuntiae Dillenii extract, 5 parts of mint extract, glycyrrhizic acid
7 parts of dipotassium, 11 parts of sodium alginate, 7 parts of permanent flower essential oil, 4 parts of Lavender, 6 parts of rosewood essential oil, 90 parts of house oil, rose
13 parts of fruit oil, 8 parts of Arabic gum and pico- 14 parts of crystalline cellulose.
Further, the raw material including following parts by weight proportion: 30 parts of Chinese mahonia leaf, 34 parts of pyracantha fortuneana leaf, folium photiniae
20 parts, 14 parts of flatcar frontal lobe, 8 parts of prairie sagewort, 14 parts of herba lysimachiae, 25 parts of Solanum nigrum, 17 parts of the coptis, 3 parts of Huai Goat, cordate houttuynia
2 parts of extract, 6 parts of Feverfew P.E, 2 parts of Valerian root P.E, 10 parts of Radix et Caulis Opuntiae Dillenii extract, 4 parts of mint extract, glycyrrhizic acid
5 parts of dipotassium, 10 parts of sodium alginate, 6 parts of permanent flower essential oil, 3 parts of Lavender, 6 parts of rosewood essential oil, 88 parts of house oil, rose
12 parts of fruit oil, 7 parts of Arabic gum and pico- 12 parts of crystalline cellulose.
Another technical problem to be solved by the present invention is that providing a kind of preparation method of ointment for treating dark sore, including following
Step:
1) by 28-33 parts of Chinese mahonia leaf, 32-35 parts of pyracantha fortuneana leaf, 12-25 parts of folium photiniae, 8-16 parts of flatcar frontal lobe, prairie sagewort
7-9 parts, 24-26 parts of wash cleans of 11-15 parts of herba lysimachiae and Solanum nigrum and the moisture for drying surface, then carry out as in juice extractor
Juice and slag charge is made in squeezing processing, spare；
2) slag charge made from step 1) and 15-20 parts of the coptis are poured into together in vessel, double weight is then added
Deionized water is heated with slow fire, is stirred continuously in heating process, heating time 1-3h, and it is spare that medical fluid is made in filtering；
3) medical fluid made from juice made from step 1) and step 2) is subjected to refined filtration processing respectively, is then poured into together
It is evaporated processing in low-temperature evaporation thickener, water content is evaporated to 25-30wt%, concentration mixed liquor is made, it is spare；
4) by 2-4 parts of Huai Goat, 1-3 parts of houttuynia extract, 5-7 parts of Feverfew P.E, Valerian root P.E 1-3
Part, 8-14 parts of Radix et Caulis Opuntiae Dillenii extract, 3-5 parts of mint extract, 2-7 parts of dipotassium glycyrrhizinate, 9-11 parts of sodium alginate, house oil 86-
90 parts, 10-13 parts of rose hip oil, 5-8 parts of Arabic gum, pico- crystalline cellulose 8-14 parts and the obtained concentration mixed liquor one of step 3)
It rising to be poured into emulsification agitator tank and carries out emulsification stir process, wherein mixing speed when emulsification treatment is 80-120r/min,
Emulsifying temperature is 45-60 DEG C, emulsification times 2-3h, and emulsion is made, spare；
5) permanent flower essential oil 5-7 parts, 2-4 parts of Lavender, 5-6 parts of rosewood essential oil are poured into emulsion, so
It is stirred at normal temperature to get ointment afterwards.
The beneficial effects of the present invention are: ingredient Chinese mahonia leaf, pyracantha fortuneana leaf, herba lysimachiae and coptis compounding can play dark sore
It can effectively prevent wound infection and hair simultaneously added with the ingredient of anti-inflammatory, antibacterial and desinsection to good therapeutic effect
Inflammation, and can kill the acarid on skin is laid a good foundation for treatment dark sore, along with taking using Lavender
Active factors with house oil, rosewood essential oil and permanent flower essential oil complement each other, rapid osmotic hair follicle disinfecting, antimicrobial, promote cell
Regeneration restores skin connective tissue, while balance skin surface layer fat secretion, sensitive skin of releiving, convergence pore, supplement skin
Moisture persistently protects skin not interfered by whelk acne, restores moist skin.
It is the effect or feature for treating the raw material of ointment of dark sore below:
Chinese mahonia leaf: heat-clearing qi-restoratives；Eliminating dampness；Removing toxic substances.Main tuberculosis hemoptysis；Osteopyrexia and fever；Dizziness and tinnitus；Waist soreness；
Jaundice with damp-heat pathogen；Leukorrhagia；Dysentery；Anemopyretic cold；Red eye, swell pain；Carbuncle swells sore；With the coptis, there is the good effect for controlling furuncle swelling toxin
Fruit.
Pyracantha fortuneana leaf: be it is a kind of can the edible ornamental of medicine multipurpose flowers and fruits plant, it is clearing heat and detoxicating.Sore swollen toxin is controlled in external application.
Folium photiniae: contain carotenoid, sakuranin, sorbierite, tannin, normal alkane, benzaldehyde, hydrogen cyanide, ursolic acid, soap
Glycosides, volatile oil etc., ursolic acid contained by Chinese photinia has apparent stable and cooling effect, and has analgesia, anti-inflammatory and antitumaous effect.
Flatcar frontal lobe: it is sweet in flavor for Plantaginaceae plant Chinese herbaceous peony and the complete stool of ordinary building, it is cold in nature.Cure mainly skin ulcer, Chinese herbaceous peony
Careless decocting liquid has significant scavenging effect, many pathologic, physiologic phenomenons such as aging, tumour, inflammation and cerebral ischemia etc. to oxygen radical
All excessively there is substantial connection with oxygen radical, while anti-inflammatory can be played the role of.
Prairie sagewort: a kind of herbaceos perennial plays the role of analgesic and anti-inflammatory.
Herba lysimachiae: being a kind of frequently seen plants, and is a kind of Chinese medicine, and primary efficacy can prevent calculus and invigorating gallbladder and removing gall-stone,
It may be said that having extraordinary treatment and prevention effect to calculus.Promoting diuresis for stranguria, clearing heat and detoxicating, eliminating stasis to subdue swelling, eliminating dampness and heat, sand
Drench, urinate it is puckery have a pain, jaundice and reddish urine, carbuncle swells furunculosis.
Solanum nigrum: antipyretic and itching-stopping, softening hard masses of reducing swelling, eliminating dampness and astringing sores, anti-corrosion remove purulence, raw cold controlling nocturnal emission with astringent drugs.Cure mainly various hot skins
Itch, carbuncle swells, thirsty, burn, suppurative smallpox, tumour, road essence etc..
The coptis: heat-clearing and damp-drying drug, purging fire for removing toxin.For carbuncle swells furunculosis；Eczema, wet sore, purulent ear canal are controlled outside.With Chinese mahonia
Leaf compounding can effectively control sore swells.
Huai Goat: there is anti-inflammatory effect.
Houttuynia extract: have it is clearing heat and detoxicating, the carbuncle that disappears row it is dense, for treating carbuncle sore tumefacting virus.
Feverfew P.E: being used as insecticide, can play the role of that acarid is inhibited even to kill acarid.
Valerian root P.E: there is antibacterial, antiviral and antitumor effect.
Radix et Caulis Opuntiae Dillenii extract: having antibacterial and antiinflammation, can effectively prevent wound and is infected by bacterial and inflammation.
Mint extract: dispelling wind-heat, refresh oneself, promoting eruption.For anemopyretic cold, wind-warm syndrome from the beginning of, headache, hot eyes, sore throat,
Aphtha, rubeola, morbilli, Breast bilges frowsty.
Dipotassium glycyrrhizinate: for white or off-white color fine powder, it is water-soluble it is good, mouthfeel is pure.Dipotassium glycyrrhizinate have it is antibacterial, disappear
The multiple efficacies such as inflammation, removing toxic substances, antiallergic, deodorization.Can in and/or lower cosmetics noxious material, the makeup being also possible to prevent
The allergic reaction of product.
Sodium alginate: being a kind of natural polysaccharide, stability, dissolubility, viscosity and peace needed for having pharmaceutical preparation auxiliary material
Quan Xing.As excipient, viscosity can be enhanced, improve the suspension of solid.The stability of emulsion can be improved.
Permanent flower essential oil: having the function of channels and collaterals of invigorating blood circulation, while can promote cytothesis, can help scar, acne, wet
The healing of rash, furuncle and abscess.
Lavender: can be clearing heat and detoxicating, cleaning skin controls oil, can promote regeneration of damaged tissue recovery, collocation
The active factors of rosewood essential oil and permanent flower essential oil complement each other, rapid osmotic hair follicle disinfecting, antimicrobial, promote cytothesis, extensive
Multiple skin connective tissue, while balance skin surface layer fat secretion, sensitive skin of releiving, convergence pore, supplement skin moisture, hold
Kubo protects skin and is not interfered by whelk acne, restores moist skin.
Rosewood essential oil: having promotion and adjustment effect for microcirculation and venous circulation, can promote cell again
It is raw, while also having the function of desinsection, sterilization, crease-resistant, moisturizing.With Feverfew P.E with good desinsection work can be played
With, remove skin on acarid.
House oil: a kind of animal oil, saturated fatty acid rich in.Nutrient (the vitamin e and linolenic acid) energy contained
Restore human body health and keep skin tender, and the immunity and resistance to disease can be reinforced.It uses the skin in human body
On the air in pore gap can be driven out of, and infiltrate into subcutaneous tissue, it is absorbed simultaneously in nutrient, not but not hinder skin
Skin breathing, and can make skin health, moisturizing and promote vis medicatrix naturae and metabolism.
Rose hip oil: its main ingredient by a variety of unsaturated fatty acids, Vitamin C, tartaric acid, soft or hard resin acid, linolenic acid and
Sunlight filterable agent composition.Deep layer moisturizing provides nutrient, keeps skin soft, soft, wet, prevents ultraviolet light to skin
It damages, skin whitening；Increase vigor of skin tissue, keeps skin high resilience, shrink coarse pore, dry cracked skin can be made
It is naturally honorable to restore it.
Arabic gum: it is a kind of safe and harmless thickener, there is good emulsification property, as emulsifier.
Microcrystalline cellulose: being the cellulose of a kind of purifying, part depolymerization, white, odorless, tasteless, by small porous particle group
At crystalline powder.Microcrystalline cellulose is widely used in the industries such as pharmacy, cosmetics, food, is used as suspending agent, can be effective
Keep the stability of emulsification.
Specific embodiment
Embodiment 1:
A kind of ointment for treating dark sore, the raw material including following parts by weight proportion: 28 parts of Chinese mahonia leaf, pyracantha fortuneana leaf 32
Part, 12 parts of folium photiniae, 8 parts of flatcar frontal lobe, 7 parts of prairie sagewort, 11 parts of herba lysimachiae, 24 parts of Solanum nigrum, 15 parts of the coptis, Huai Goat 2
Part, 1 part of houttuynia extract, 5 parts of Feverfew P.E, 1 part of Valerian root P.E, 8 parts of Radix et Caulis Opuntiae Dillenii extract, mint extract 3
Part, 2 parts of dipotassium glycyrrhizinate, 9 parts of sodium alginate, 5 parts of permanent flower essential oil, 2 parts of Lavender, 5 parts of rosewood essential oil, house oil 86
Part, 10 parts of rose hip oil, 5 parts of Arabic gum and pico- 8 parts of crystalline cellulose.
A kind of preparation method of ointment that treating dark sore the following steps are included:
1) by 28 parts of Chinese mahonia leaf, 32 parts of pyracantha fortuneana leaf, 12 parts of folium photiniae, 8 parts of flatcar frontal lobe, 7 parts of prairie sagewort, herba lysimachiae 11
Part and 24 parts of wash cleans of Solanum nigrum and dry the moisture on surface, then as squeezing processing is carried out in juice extractor, be made juice and
Slag charge, it is spare；
2) slag charge made from step 1) and 15 parts of the coptis are poured into together in vessel, then be added double weight go from
Sub- water, is heated with slow fire, is stirred continuously in heating process, heating time 1h, and it is spare that medical fluid is made in filtering；
3) medical fluid made from juice made from step 1) and step 2) is subjected to refined filtration processing respectively, is then poured into together
It is evaporated processing in low-temperature evaporation thickener, water content is evaporated to 25wt%, concentration mixed liquor is made, it is spare；
4) by 2 parts of Huai Goat, 1 part of houttuynia extract, 5 parts of Feverfew P.E, 1 part of Valerian root P.E, celestial being
Slap 8 parts of extract, 3 parts of mint extract, 2 parts of dipotassium glycyrrhizinate, 9 parts of sodium alginate, 86 parts of house oil, 10 parts of rose hip oil, Ah
It draws the obtained concentration mixed liquor of primary 5 parts of glue, 8 parts of pico- crystalline cellulose and step 3) to be poured into together in emulsification agitator tank to be emulsified
Stir process, wherein mixing speed when emulsification treatment is 80r/min, and emulsifying temperature is 45 DEG C, emulsification times 2h, is made
Emulsion, it is spare；
5) 5 parts of permanent flower essential oil, 2 parts of Lavender, 5 parts of rosewood essential oil are poured into emulsion, then normal
It stirs under temperature to get ointment.
Embodiment 2:
A kind of ointment for treating dark sore, the raw material including following parts by weight proportion: 33 parts of Chinese mahonia leaf, pyracantha fortuneana leaf 35
Part, 25 parts of folium photiniae, 16 parts of flatcar frontal lobe, 9 parts of prairie sagewort, 15 parts of herba lysimachiae, 26 parts of Solanum nigrum, 20 parts of the coptis, Huai Goat 4
Part, 3 parts of houttuynia extract, 7 parts of Feverfew P.E, 3 parts of Valerian root P.E, 14 parts of Radix et Caulis Opuntiae Dillenii extract, mint extract 5
Part, 7 parts of dipotassium glycyrrhizinate, 11 parts of sodium alginate, 7 parts of permanent flower essential oil, 4 parts of Lavender, 6 parts of rosewood essential oil, house oil
90 parts, 13 parts of rose hip oil, 8 parts of Arabic gum and pico- 14 parts of crystalline cellulose.
A kind of preparation method of ointment that treating dark sore, comprising the following steps:
1) by 33 parts of Chinese mahonia leaf, 35 parts of pyracantha fortuneana leaf, 25 parts of folium photiniae, 16 parts of flatcar frontal lobe, 9 parts of prairie sagewort, herba lysimachiae
Juice is made then as squeezing processing is carried out in juice extractor in 15 parts and 26 parts of wash cleans of Solanum nigrum and the moisture for drying surface
And slag charge, it is spare；
2) slag charge made from step 1) and 20 parts of the coptis are poured into together in vessel, then be added double weight go from
Sub- water, is heated with slow fire, is stirred continuously in heating process, heating time 3h, and it is spare that medical fluid is made in filtering；
3) medical fluid made from juice made from step 1) and step 2) is subjected to refined filtration processing respectively, is then poured into together
It is evaporated processing in low-temperature evaporation thickener, water content is evaporated to 30wt%, concentration mixed liquor is made, it is spare；
4) by 4 parts of Huai Goat, 3 parts of houttuynia extract, 7 parts of Feverfew P.E, 3 parts of Valerian root P.E, celestial being
Slap 14 parts of extract, 5 parts of mint extract, 7 parts of dipotassium glycyrrhizinate, 11 parts of sodium alginate, 90 parts of house oil, 13 parts of rose hip oil,
The obtained concentration mixed liquor of 8 parts of Arabic gum, 14 parts of pico- crystalline cellulose and step 3), which is poured into together in emulsification agitator tank, to carry out
Emulsifying stir process, wherein mixing speed when emulsification treatment is 120r/min, and emulsifying temperature is 60 DEG C, emulsification times 3h,
Emulsion is made, it is spare；
5) 7 parts of permanent flower essential oil, 4 parts of Lavender, 6 parts of rosewood essential oil are poured into emulsion, then normal
It stirs under temperature to get ointment.
Embodiment 3:
A kind of ointment for treating dark sore, the raw material including following parts by weight proportion: 30 parts of Chinese mahonia leaf, pyracantha fortuneana leaf 34
Part, 20 parts of folium photiniae, 14 parts of flatcar frontal lobe, 8 parts of prairie sagewort, 14 parts of herba lysimachiae, 25 parts of Solanum nigrum, 17 parts of the coptis, Huai Goat 3
Part, 2 parts of houttuynia extract, 6 parts of Feverfew P.E, 2 parts of Valerian root P.E, 10 parts of Radix et Caulis Opuntiae Dillenii extract, mint extract 4
Part, 5 parts of dipotassium glycyrrhizinate, 10 parts of sodium alginate, 6 parts of permanent flower essential oil, 3 parts of Lavender, 6 parts of rosewood essential oil, house oil
88 parts, 12 parts of rose hip oil, 7 parts of Arabic gum and pico- 12 parts of crystalline cellulose.
A kind of preparation method of ointment that treating dark sore, comprising the following steps:
1) by 30 parts of Chinese mahonia leaf, 34 parts of pyracantha fortuneana leaf, 20 parts of folium photiniae, 14 parts of flatcar frontal lobe, 8 parts of prairie sagewort, herba lysimachiae
Juice is made then as squeezing processing is carried out in juice extractor in 14 parts and 25 parts of wash cleans of Solanum nigrum and the moisture for drying surface
And slag charge, it is spare；
2) slag charge made from step 1) and 17 parts of the coptis are poured into together in vessel, then be added double weight go from
Sub- water, is heated with slow fire, is stirred continuously in heating process, heating time 2h, and it is spare that medical fluid is made in filtering；
3) medical fluid made from juice made from step 1) and step 2) is subjected to refined filtration processing respectively, is then poured into together
It is evaporated processing in low-temperature evaporation thickener, water content is evaporated to 28wt%, concentration mixed liquor is made, it is spare；
4) by 3 parts of Huai Goat, 2 parts of houttuynia extract, 6 parts of Feverfew P.E, 2 parts of Valerian root P.E, celestial being
Slap 10 parts of extract, 4 parts of mint extract, 5 parts of dipotassium glycyrrhizinate, 10 parts of sodium alginate, 88 parts of house oil, 12 parts of rose hip oil,
The obtained concentration mixed liquor of 7 parts of Arabic gum, 12 parts of pico- crystalline cellulose and step 3), which is poured into together in emulsification agitator tank, to carry out
Emulsifying stir process, wherein mixing speed when emulsification treatment is 100r/min, and emulsifying temperature is 55 DEG C, emulsification times 3h,
Emulsion is made, it is spare；
5) 6 parts of permanent flower essential oil, 3 parts of Lavender, 6 parts of rosewood essential oil are poured into emulsion, then normal
It stirs under temperature to get ointment.
Experimental example:
Efficacy assessments test, test operation specification are carried out to ointment obtained in embodiment 1, embodiment 2 and embodiment 3
It is carried out according to " cosmetics health specification ".Choose the health of 120 18-40 one full year of life, the face without cosmetic allergic contact dermatitis history has
Volunteer (male 60, women 60) of dark sore test as study subject.Subject is randomly divided into 4 groups, every group of male
Female each 15, respectively using ointment and market made from ointment made from ointment made from embodiment 1, embodiment 2, embodiment 3
On acne cream, respectively as experimental group one, experimental group two, experimental group three and control group.After its method is face cleaning daily morning and evening
Sample is applied at dark sore, using observation affected part after 1 month and is evaluated.
4 groups of user 1 month effect compares, and as a result see the table below:
By checking that the using effect of experimental group one, experimental group two and experimental group three compares control group to 4 groups of experiments
It is better.
The beneficial effects of the present invention are: ingredient Chinese mahonia leaf, pyracantha fortuneana leaf, herba lysimachiae and coptis compounding can play dark sore
It can effectively prevent wound infection and hair simultaneously added with the ingredient of anti-inflammatory, antibacterial and desinsection to good therapeutic effect
Inflammation, and can kill the acarid on skin is laid a good foundation for treatment dark sore, along with taking using Lavender
Active factors with house oil, rosewood essential oil and permanent flower essential oil complement each other, rapid osmotic hair follicle disinfecting, antimicrobial, promote cell
Regeneration restores skin connective tissue, while balance skin surface layer fat secretion, sensitive skin of releiving, convergence pore, supplement skin
Moisture persistently protects skin not interfered by whelk acne, restores moist skin.
The above description is merely a specific embodiment, but scope of protection of the present invention is not limited thereto, any
The change or replacement expected without creative work, should be covered by the scope of protection of the present invention.
Claims (5)
1. a kind of ointment for treating dark sore, which is characterized in that the raw material including following parts by weight proportion: Chinese mahonia leaf 28-
33 parts, 32-35 parts of pyracantha fortuneana leaf, 12-25 parts of folium photiniae, 8-16 parts of flatcar frontal lobe, 7-9 parts of prairie sagewort, 11-15 parts of herba lysimachiae, black nightshade
24-26 parts of fruit, 15-20 parts of the coptis, 2-4 parts of Huai Goat, 1-3 parts of houttuynia extract, 5-7 parts of Feverfew P.E, figured silk fabrics
Careless extract 1-3 parts, 8-14 parts of Radix et Caulis Opuntiae Dillenii extract, 3-5 parts of mint extract, 2-7 parts of dipotassium glycyrrhizinate, sodium alginate 9-11
Part, flower essential oil 5-7 parts permanent, 2-4 parts of Lavender, 5-6 parts of rosewood essential oil, 86-90 parts of house oil, rose hip oil 10-13
Part, 5-8 parts of Arabic gum and pico- 8-14 parts of crystalline cellulose.
2. a kind of ointment for treating dark sore as described in claim 1, which is characterized in that the original including following parts by weight proportion
Material: 28 parts of Chinese mahonia leaf, 32 parts of pyracantha fortuneana leaf, 12 parts of folium photiniae, 8 parts of flatcar frontal lobe, 7 parts of prairie sagewort, 11 parts of herba lysimachiae, Solanum nigrum
24 parts, 15 parts of the coptis, 2 parts of Huai Goat, 1 part of houttuynia extract, 5 parts of Feverfew P.E, 1 part of Valerian root P.E, celestial being
People slaps 8 parts of extract, 3 parts of mint extract, 2 parts of dipotassium glycyrrhizinate, 9 parts of sodium alginate, 5 parts of permanent flower essential oil, lavender essence
2 parts of oil, 5 parts of rosewood essential oil, 86 parts of house oil, 10 parts of rose hip oil, 5 parts of Arabic gum and pico- 8 parts of crystalline cellulose.
3. a kind of ointment for treating dark sore as described in claim 1, which is characterized in that the original including following parts by weight proportion
Material: 33 parts of Chinese mahonia leaf, 35 parts of pyracantha fortuneana leaf, 25 parts of folium photiniae, 16 parts of flatcar frontal lobe, 9 parts of prairie sagewort, 15 parts of herba lysimachiae, black nightshade
26 parts of fruit, 20 parts of the coptis, 4 parts of Huai Goat, 3 parts of houttuynia extract, 7 parts of Feverfew P.E, 3 parts of Valerian root P.E,
14 parts of Radix et Caulis Opuntiae Dillenii extract, 7 parts of dipotassium glycyrrhizinate, 11 parts of sodium alginate, 7 parts of permanent flower essential oil, smokes clothing at 5 parts of mint extract
4 parts of careless essential oil, 6 parts of rosewood essential oil, 90 parts of house oil, 13 parts of rose hip oil, 8 parts of Arabic gum and pico- 14 parts of crystalline cellulose.
4. a kind of ointment for treating dark sore as described in claim 1, which is characterized in that the original including following parts by weight proportion
Material: 30 parts of Chinese mahonia leaf, 34 parts of pyracantha fortuneana leaf, 20 parts of folium photiniae, 14 parts of flatcar frontal lobe, 8 parts of prairie sagewort, 14 parts of herba lysimachiae, black nightshade
25 parts of fruit, 17 parts of the coptis, 3 parts of Huai Goat, 2 parts of houttuynia extract, 6 parts of Feverfew P.E, 2 parts of Valerian root P.E,
10 parts of Radix et Caulis Opuntiae Dillenii extract, 5 parts of dipotassium glycyrrhizinate, 10 parts of sodium alginate, 6 parts of permanent flower essential oil, smokes clothing at 4 parts of mint extract
3 parts of careless essential oil, 6 parts of rosewood essential oil, 88 parts of house oil, 12 parts of rose hip oil, 7 parts of Arabic gum and pico- 12 parts of crystalline cellulose.
5. a kind of preparation method for the ointment for treating dark sore, which comprises the following steps:
1) by 28-33 parts of Chinese mahonia leaf, 32-35 parts of pyracantha fortuneana leaf, 12-25 parts of folium photiniae, 8-16 parts of flatcar frontal lobe, prairie sagewort 7-9
Part, 24-26 parts of wash cleans of 11-15 parts of herba lysimachiae and Solanum nigrum and the moisture for drying surface, then as being pressed in juice extractor
Juice and slag charge is made in squeezing processing, spare；
2) slag charge made from step 1) and 15-20 parts of the coptis are poured into together in vessel, then be added double weight go from
Sub- water, is heated with slow fire, is stirred continuously in heating process, heating time 1-3h, and it is spare that medical fluid is made in filtering；
3) medical fluid made from juice made from step 1) and step 2) is subjected to refined filtration processing respectively, is then poured into low temperature together
It is evaporated processing in concentrator, water content is evaporated to 25-30wt%, concentration mixed liquor is made, it is spare；
4) by 2-4 parts of Huai Goat, 1-3 parts of houttuynia extract, 5-7 parts of Feverfew P.E, 1-3 parts of Valerian root P.E,
8-14 parts of Radix et Caulis Opuntiae Dillenii extract, 3-5 parts of mint extract, 2-7 parts of dipotassium glycyrrhizinate, 9-11 parts of sodium alginate, house oil 86-90
Concentration mixed liquor is made together in part, 10-13 parts of rose hip oil, 5-8 parts of Arabic gum, pico- crystalline cellulose 8-14 parts and step 3)
It is poured into emulsification agitator tank and carries out emulsification stir process, wherein mixing speed when emulsification treatment is 80-120r/min, cream
Changing temperature is 45-60 DEG C, emulsification times 2-3h, and emulsion is made, spare；
5) permanent flower essential oil 5-7 parts, 2-4 parts of Lavender, 5-6 parts of rosewood essential oil are poured into emulsion, are then existed
It stirs under room temperature to get ointment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810911680.0A CN109010520A (en) | 2018-08-10 | 2018-08-10 | A kind of ointment and preparation method thereof for treating dark sore |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810911680.0A CN109010520A (en) | 2018-08-10 | 2018-08-10 | A kind of ointment and preparation method thereof for treating dark sore |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109010520A true CN109010520A (en) | 2018-12-18 |
Family
ID=64632794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810911680.0A Withdrawn CN109010520A (en) | 2018-08-10 | 2018-08-10 | A kind of ointment and preparation method thereof for treating dark sore |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109010520A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110777019A (en) * | 2019-11-11 | 2020-02-11 | 荆州市活力二八家化有限公司 | Fabric detergent containing dodecyl diethylenetriamine and having mite killing function |
| WO2023180126A1 (en) | 2022-03-24 | 2023-09-28 | Laboratoires M&L | Cosmetic use of a combination of immortelle extracts to reduce the visibility of skin pores |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104498221A (en) * | 2014-12-10 | 2015-04-08 | 山东科技职业学院 | Production method of ginger-milk-horse oil soap |
| CN105456063A (en) * | 2015-12-14 | 2016-04-06 | 安徽丰乐香料有限责任公司 | Cool and refreshing skin-caring essential oil |
| CN105919898A (en) * | 2016-06-27 | 2016-09-07 | 聂超 | Chinese herbal medicinal whitening and acne removing facial cleanser |
| CN108042695A (en) * | 2017-12-30 | 2018-05-18 | 朱增伟 | Treat the Chinese medicine preparation of acne |
-
2018
- 2018-08-10 CN CN201810911680.0A patent/CN109010520A/en not_active Withdrawn
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104498221A (en) * | 2014-12-10 | 2015-04-08 | 山东科技职业学院 | Production method of ginger-milk-horse oil soap |
| CN105456063A (en) * | 2015-12-14 | 2016-04-06 | 安徽丰乐香料有限责任公司 | Cool and refreshing skin-caring essential oil |
| CN105919898A (en) * | 2016-06-27 | 2016-09-07 | 聂超 | Chinese herbal medicinal whitening and acne removing facial cleanser |
| CN108042695A (en) * | 2017-12-30 | 2018-05-18 | 朱增伟 | Treat the Chinese medicine preparation of acne |
Non-Patent Citations (5)
| Title |
|---|
| 上海钾盐工程技术研究中心: "《中国钾盐工业概览》", 31 July 2009, 上海交通大学出版社 * |
| 小猫刷牙: "nyr新品第二波", 《新浪博客》 * |
| 屈娴: "《精油完全使用手册》", 31 August 2011, 江西科学技术出版社 * |
| 王高荣: "《芳香美人》", 31 May 2006, 科学技术文献出版社 * |
| 边惠玉: "《100元搞定日系美妆潮品》", 30 April 2014, 广西科学技术出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110777019A (en) * | 2019-11-11 | 2020-02-11 | 荆州市活力二八家化有限公司 | Fabric detergent containing dodecyl diethylenetriamine and having mite killing function |
| WO2023180126A1 (en) | 2022-03-24 | 2023-09-28 | Laboratoires M&L | Cosmetic use of a combination of immortelle extracts to reduce the visibility of skin pores |
| FR3133756A1 (en) * | 2022-03-24 | 2023-09-29 | Laboratoires M&L | Cosmetic use of a combination of immortelle extracts to reduce the visibility of skin pores |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103571657B (en) | A kind of natural soap except acne and preparation method thereof | |
| CN102342993B (en) | Anti-sensitization and restoration external preparation for skin | |
| CN105213284A (en) | A kind of anti-acne moisturiser and preparation method thereof | |
| CN105106655B (en) | A kind of prosthetic burn and scald ointment and preparation method thereof | |
| CN106398918A (en) | Handmade soap with effects of cleaning skin and removing mites | |
| CN113018238A (en) | Anti-bacterial, anti-inflammatory, refreshing and skin-benefiting acne-removing gel and preparation method thereof | |
| CN106511211B (en) | Anti-inflammatory acne-removing skin-care lotion and preparation method thereof | |
| CN105062725A (en) | Handmade soap capable of removing acnes and beautifying skin, and preparation method thereof | |
| CN109010520A (en) | A kind of ointment and preparation method thereof for treating dark sore | |
| CN105030620A (en) | Moisturizing and acne removing facial cleanser and preparing method thereof | |
| CN104887603A (en) | Skin moisturizer containing jasmine essential oil | |
| CN106333918A (en) | After-sun repair attapulgite face cream | |
| CN106667850A (en) | Traditional Chinese medicine mask liquid for removing acne and preparation method thereof | |
| CN105213285A (en) | A kind of anti-acne facial cleanser and preparation method thereof | |
| CN105412415A (en) | Medicine composition removing acnes | |
| CN105168091A (en) | Telangiectasis removing mask powder and preparation method thereof | |
| CN111040896A (en) | Antibacterial, anti-inflammatory and skin-beautifying handmade soap | |
| CN110151657B (en) | Acne removing gel containing sedum sarmentosum extract and preparation method thereof | |
| CN105687051A (en) | Bath salt with acne removal effect and preparation method | |
| CN103028101B (en) | Medicinal liquid for treating acne | |
| CN110934785A (en) | Whitening and moisturizing facial cleanser for sensitive skin and preparation method thereof | |
| CN105687049A (en) | Bath salt capable of effectively removing face pimples and preparation method | |
| CN105106085A (en) | Chinese medicinal herb sunscreen cream containing attapulgite | |
| CN108929811A (en) | A kind of wormwood handmade soap | |
| CN108524298A (en) | Nti-freckle therapeutic massage of losing weight is white |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20181218 |
|
| WW01 | Invention patent application withdrawn after publication |